Biotechnology Spruce Biosciences’ Hormone Treatment Stumbles In Trials, Prompts Stock Freefall Spruce Biosciences’ Hormonal Disorder Candidate’s Future in Limbo: Analysts Downgrade Amid Tildacerfont’s Trial Setback – Spruce Biosciences (NASDAQ:SPRB) Read more
Biotechnology Biogen’s Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers – Biogen (NASDAQ:BIIB) Read more
Biotechnology Allergic Reaction Focused ARS Pharmaceuticals’ Lead Candidate Shows Efficacy In Skin Disorder – ARS Pharmaceuticals (NASDAQ:SPRY) Read more
Biotechnology Good News For Sleep Disorder Patients – Takeda’s Therapy Shows Promise In Mid-Stage Study – Takeda Pharmaceutical (NYSE:TAK) Read more
Biotechnology Vertex Pharmaceuticals’ Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients – Vertex Pharmaceuticals (NASDAQ:VRTX) Read more
Biotechnology PTC Therapeutics To Withdraw Its Conditionally Approved Rare Muscle Disorder Disorder Drug In Europe – PTC Therapeutics (NASDAQ:PTCT) Read more